MGMT and glioblastoma: The DNA alkylating agent, temozolomide, is the gold standard drug in the treatment of GBM, but its efficacy is limited and restricted to GBM cells that do not express the resistance enzyme, O6-methylguanine-DNA methyltransferase (MGMT) [6].